Ameriprise Financial Inc Arcus Biosciences, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,319,266 shares of RCUS stock, worth $21 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,319,266

Previous 1,474,438 10.52%

Holding current value

$21 Million

Previous $22.5 Million 10.17%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$13.69 - $18.01 $2.12 Million - $2.79 Million	-155,172 Reduced 10.52%	1,319,266 $20.2 Million
Q2 2024 Aug 14, 2024	BUY	$14.59 - $18.48 $3.99 Million - $5.05 Million	273,417 Added 22.77%	1,474,438 $22.5 Million
Q1 2024 May 15, 2024	SELL	$14.83 - $20.18 $6.43 Million - $8.75 Million	-433,784 Reduced 26.53%	1,201,021 $22.7 Million
Q4 2023 Feb 14, 2024	BUY	$13.43 - $19.63 $737,051 - $1.08 Million	54,881 Added 3.47%	1,634,805 $31.2 Million
Q3 2023 Nov 14, 2023	BUY	$17.62 - $23.54 $1.8 Million - $2.4 Million	101,928 Added 6.9%	1,579,924 $28.4 Million
Q2 2023 Aug 14, 2023	BUY	$16.97 - $22.03 $21.8 Million - $28.3 Million	1,282,961 Added 657.81%	1,477,996 $30 Million
Q1 2023 May 15, 2023	SELL	$15.96 - $23.15 $144,709 - $209,901	-9,067 Reduced 4.44%	195,035 $3.56 Million
Q4 2022 Feb 14, 2023	SELL	$19.7 - $35.71 $97,633 - $176,978	-4,956 Reduced 2.37%	204,102 $4.22 Million
Q3 2022 Nov 14, 2022	BUY	$23.23 - $30.07 $387,127 - $501,116	16,665 Added 8.66%	209,058 $5.47 Million
Q2 2022 Aug 15, 2022	BUY	$17.23 - $37.73 $3.31 Million - $7.26 Million	192,393 New	192,393 $4.88 Million
Q4 2021 Feb 14, 2022	SELL	$31.38 - $48.47 $9.36 Million - $14.5 Million	-298,410 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$22.75 - $35.77 $24.4 Million - $38.3 Million	-1,071,985 Reduced 78.22%	298,410 $8.2 Million
Q1 2021 May 17, 2021	SELL	$26.16 - $41.39 $156,907 - $248,257	-5,998 Reduced 0.44%	1,370,395 $38.5 Million
Q4 2020 Feb 12, 2021	BUY	$17.0 - $32.36 $23.4 Million - $44.5 Million	1,376,393 New	1,376,393 $35.7 Million

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.15B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Arcus Biosciences, Inc. Transaction History